Please fill the form below to make an appointment with the International Medicine Department . Once the International Medicine Department receives your request of appointment, we will contact you to confirm your visit.
CareFor Oversea Patients
Research on the molecular mechanism involved in HCC immunotherapy failure in HEPATOLOGY
Recently,SULT2B1 CS DOCK2 Axis Regulates Effector T Cell Exhaustion in Hepatocellular Carcinoma Microenvironmentwas published in the journalHEPATOLOGYbyProfessor Xu Xiao(corresponding author)from Affi...
Research on level of tenofovir in breast milk of HBV-infected mothers by Professor Lin and Jin’s team in International Journal of Antimicrobial Agents
Recently, The low level of tenofovir in breast milk supports breastfeeding in HBV-infected mothershas been published in the International Journal of Antimicrobial Agentsby Prof Lin Neng Ming（Departme...
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, founded in 1923, is one of the first four hospitals in Zhejiang Province to pass the Triple-A accreditation, and one of the hospitals with the most complete clinical disciplines and the strongest service capacity in Zhejiang Province, with the leading service capacity in general surgery, cardiovascular and metabolic diseases, gastroenterology, oncology, hematology and rare diseases, obstetrics and gynecology and pediatrics in China. There are 34 provincial and municipal key disciplines, specialties and regional specialized centers. As the first model hospital exploring group management and medical association construction in Zhejiang Province, it has 9 hospital districts, 24 medical association units and more than 5,000 open beds. It ranks 59th in the performance assessment of national tertiary public hospitals with grade A+.
The Hepatobiliary pancreatic surgery research center is mainly engaged in the research in the following three subjects.: 1) research on molecular typing and targeted therapy of hepatobiliary pancreatic malignancies; 2) basic and clinical research on prevention and treatment of liver transplantation complications; 3) research on diagnosis and treatment technology with intelligent and innovative medicine. Relying on the rich clinical resources and powerful policy support of affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, the center aims at the major health needs of China and provides a solid foundation for the continuous improvement of cancer prevention and control.